Distress in neurocognitive disorders due to Alzheimer's disease and stroke

Dindelegan,Camelia   Maria; Faur,Darian; Purza,Lavinia; Bumbu,Adrian; Sabau,Monica

doi:10.3892/etm.2020.8806

Distress in neurocognitive disorders due to Alzheimer's disease and stroke

Authors:
- Camelia Maria Dindelegan
- Darian Faur
- Lavinia Purza
- Adrian Bumbu
- Monica Sabau
View Affiliations

Affiliations: Psychology Department, Faculty of Social Humanistic Science, University of Oradea, 410087 Oradea, Romania, Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania, Department of Psycho‑Neurosciences and Rehabilitation, Faculty of Medicine and Pharmacy, University of Oradea, 410068 Oradea, Romania
Published online on: May 28, 2020 https://doi.org/10.3892/etm.2020.8806
Pages: 2501-2509

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Patients with neurocognitive disorders experience subjectively the concept of quality of life; this is the reason why researchers avoid approaching this concept and prefer to focus attention on the emotional profile of the caregivers. Many studies highlight the efforts both emotional and financial made by caregivers in case of patients diagnosed with neurocognitive disorders. The present study shows the differences between the patients diagnosed with neurocognitive disorder due to Alzheimer's disease and patients diagnosed with stroke, as well as the Romanian norms for the short form of Geriatric Depression Scale. The study group consisted of the clinical population (N=45), selected according to the inclusion/exclusion criteria, following the principles of Helsinki Declaration for Ethical Medical Research. The study was conducted at the Neuropsychiatry section of the Municipal Clinical Hospital, Dr Gavril Curteanu, Oradea, Romania. The results showed significant differences between the two types of patients in terms of quality of life, t(43)=‑7.99, P=0.001, affective distress, t(43)=5.10, P=0.001 and perceived stress, t(43)=3.81, P=0.001. The internal consistency of the scale is high, the coefficient KR‑20 being 0.86.

View Figures

View References

1	Etters L, Goodall D and Harrison BE: Caregiver burden among dementia patient caregivers: A review of the literature. J Am Acad Nurse Pract. 20:423–428. 2008.PubMed/NCBI View Article : Google Scholar
2	Wolstenholme J, Fenn P, Gray A, Keene J, Jacoby R and Hope T: Estimating the relationship between disease progression and cost of care in dementia. Br J Psychiatry. 181:36–42. 2002.PubMed/NCBI View Article : Google Scholar
3	Uivarosan D, Bungau S, Tit DM, Moisa C, Fratila O, Rus M, Bratu OG, Diaconu CC and Pantis C: Financial burden of stroke reflected in a pilot center for the implementation of thrombolysis. Medicina (Kaunas). 56(54)2020.PubMed/NCBI View Article : Google Scholar
4	Purza L, Abdel-Daim M, Belba A, Iovan C, Bumbu A, Lazar L, Bungau S and Tit DM: Monitoring the effects of various combination of specific drug therapies at different stages of Alzheimer's dementia. Farmacia. 67:477–481. 2019. View Article : Google Scholar
5	Mucke L: Alzheimer's disease. Nature. 461:895–897. 2009.PubMed/NCBI
6	Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P and Zerr I: Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: A critical analysis. J Neurol. 260:2722–2727. 2013.PubMed/NCBI View Article : Google Scholar
7	Fodor K, Tit DM, Pasca B, Bustea C, Uivarosan D, Endres L, Iovan C, Abdel-Daim MM and Bungau S: Long-term resveratrol supplementation as a secondary prophylaxis for stroke. Oxid Med Cell Longev. 2018(4147320)2018. View Article : Google Scholar
8	Sabau M, Bungau S, Buhas CL, Carp G, Daina LG, Judea-Pusta CT, Buhas BA, Jurca CM, Daina CM and Tit DM: Legal medicine implications in fibrinolytic therapy of acute ischemic stroke. BMC Med Ethics. 20(70)2019. View Article : Google Scholar
9	Uivarosan D, Tit DM, Iovan C, Nistor-Cseppento DC, Endres L, Lazar L, Sava C, Sabau AM, Buhas C, Moleriu LC, et al: Effects of combining modern recovery techniques with neurotrophic medication and standard treatment in stroke patients. Sci Total Environ. 679:80–87. 2019.PubMed/NCBI View Article : Google Scholar
10	Series H and Esiri M: Vascular dementia: A pragmatic review. Adv Psychiatr Treat. 18:372–380. 2012. View Article : Google Scholar
11	Jellinger KA: Pathology and pathogenesis of vascular cognitive impairment - a critical update. Front Aging Neurosci. 5(17)2013.PubMed/NCBI
12	Cohen D: The subjective experience of Alzheimer's disease: The anatomy of an illness as perceived by patients and families. Am J Alzheimer's Care Relat Disord Res. 6:6–11. 1991. View Article : Google Scholar
13	Ştefan AM and Băban A: The Romanian version of the Geriatric Depression Scale: Reliability and validity. Cogn Brain Behav. 21:175–187. 2017. View Article : Google Scholar
14	Preoteasa CT and Preoteasa E: Psychometric properties of romanian version of who-5 well-being index in dental students. Rom J Oral Rehabil. 7:21–27. 2015.
15	Opriş D and Macovei M: The profile of emotional distress; Norms for the Romanian population. JEBP Psychother. 7:139–158. 2007.
16	Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Luzi C and Andreoli A: Development of the Perceived Stress Questionnaire: A new tool for psychosomatic research. J Psychosom Res. 37:19–32. 1993.PubMed/NCBI View Article : Google Scholar
17	Băban A (ed): Stress and Personality. Vol 1. 1st edition. Presa Universitară Clujeană, Cluj-Napoca. pp12–43. 1998.PubMed/NCBI(In Romanian).
18	DeBettignies BH, Mahurin RK and Pirozzolo FJ: Insight for impairment in independent living skills in Alzheimer's disease and multi-infarct dementia. J Clin Exp Neuropsychol. 12:355–363. 1990.PubMed/NCBI View Article : Google Scholar
19	Fuh JL, Wang SJ and Cummings JL: Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia. J Neurol Neurosurg Psychiatry. 76:1337–1341. 2005.PubMed/NCBI View Article : Google Scholar
20	Sultzer DL, Levin HS, Mahler ME, High WM and Cummings JL: A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry. 150:1806–1812. 1993.PubMed/NCBI View Article : Google Scholar
21	Aznar S and Knudsen GM: Depression and Alzheimer's disease: Is stress the initiating factor in a common neuropathological cascade? J Alzheimers Dis. 23:177–193. 2011.PubMed/NCBI View Article : Google Scholar
22	Abdel-Daim MM, El-Tawil OS, Bungau SG and Atanasov AG: Applications of antioxidants in metabolic disorders and degenerative diseases: Mechanistic approach. Oxid Med Cell Longev. 2019(4179676)2019.PubMed/NCBI
23	Abdel-Daim MM, Zakhary NI, Aleya L, Bungău SG, Bohara RA and Siddiqi NJ: Aging, metabolic, and degenerative disorders: Biomedical value of antioxidants. Oxid Med Cell Longev. 2018(2098123)2018.PubMed/NCBI View Article : Google Scholar
24	Narushima K and Robinson RG: Stroke-related depression. Curr Atheroscler Rep. 4:296–303. 2002.
25	Orgeta V, Qazi A, Spector A and Orrell M: Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: Systematic review and meta-analysis. Br J Psychiatry. 207:293–298. 2015.PubMed/NCBI View Article : Google Scholar
26	Roman-Filip C, Ungureanu A and Cernuşcă-Miţaru M: Painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder. Neurol Neurochir Pol. 50:55–58. 2016.PubMed/NCBI View Article : Google Scholar
27	Ungureanu A, Rus L, Gligor F, Lazaroae A, Prodan L and Roman-Filip C: Intravenous levetiracetam as second line treatment for status epilepticus. Farmacia. 64:507–511. 2017.